Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Drone Manufacturers Quantum and Destinus Reportedly Engage Banks for Potential 2027 IPOs Maines Groundfishing Industry Faces Inflation Squeeze Free Fillet Program Offers Potential Lifeline Japan Shipbuilding Town Turns to Foreign Workers and AI to Address Labor Shortage Oil Market Nearing Minimum Operating Levels Across Asia and Europe Warns Carlyles Jeff Currie US Q1 GDP Growth Revised Down to 16 as Consumer Spending Shows Signs of Slowing Alumis Inc ALMS Q1 2026 Earnings Narrower Loss Mirrors Operational Discipline PreRevenue Stage Persists MLM Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains on Resilient Demand UFPI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Reaction ECL Q1 2026 Earnings Slight EPS Miss Amid Steady Performance Shares Edge Higher CFFI Q1 2026 Earnings Solid EPS Performance Amid Quiet Market Reception Seaport Entertainment Group Q1 2026 Earnings EPS Misses Estimates Amid Operational Development ProAssurance PRA Holds Steady Near 2462 as Market Awaits Catalysts RH RH Rallies 245 as Shares Test Resistance Near 149 VanEck Avalanche ETF VAVX Slips 26 as CryptoLinked Securities Face Renewed Pressure Crown Reserve Acquisition Corp I Rights CRACR Holds Steady at 015 Amid Limited Trading Activity Pennant Group PNTG Dips 194 as Stock Approaches Key Support Zone NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline Vodafone Q4 2025 Earnings EPS Beat of 4078 Surprises but Stock Slips on Cautious Outlook NICE Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Reaction APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly Agree Realty Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Operational Performance Cisco Systems CSCO Posts Record Revenue in Fiscal Q3 2026 Solidifying Its Position as a Top Tech Hold in Ken Fishers Portfolio Unitil Corporation UTL Q1 2026 Earnings EPS Slightly Beats Estimates Revenue Not Disclosed Traws Pharma TRAW Holds Steady at 149 as Stock Finds Balance Between Key Levels